openPR Logo

Press Releases from Dermatomyositis Therapeutics- Pharma Proff (1 total)

Dermatomyositis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results, …

Dermatomyositis is a rare inflammatory disease which can occur in any age. However, it is most common in children age group of 5 to 15

Go To Page: